-
XENE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Xenon Pharmaceuticals (XENE)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 87.62 mm | 87.62 mm | 87.62 mm | 87.62 mm | 87.62 mm | |
Cash burn (monthly) | (no burn) | (no burn) | 24.56 mm | 20.17 mm | 10.07 mm | |
Cash used (since last report) | n/a | n/a | 68.75 mm | 56.47 mm | 28.20 mm | |
Cash remaining | n/a | n/a | 18.88 mm | 31.15 mm | 59.43 mm | |
Runway (months of cash) | n/a | n/a | 0.8 | 1.5 | 5.9 |
13F holders | Current |
---|---|
Total holders | 211 |
Opened positions | 48 |
Closed positions | 21 |
Increased positions | 66 |
Reduced positions | 58 |
13F shares | Current |
---|---|
Total value | 2.74 tn |
Total shares | 75.37 mm |
Total puts | 60.70 k |
Total calls | 59.70 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
FMR | 6.77 mm | $263.89 bn |
Avoro Capital Advisors | 5.67 mm | $220.94 bn |
Driehaus Capital Management | 4.42 mm | $172.32 bn |
Wellington Management | 3.83 mm | $149.26 bn |
Commodore Capital | 2.75 mm | $107.39 bn |
Capital World Investors | 2.68 mm | $104.55 bn |
Braidwell | 2.56 mm | $99.84 bn |
Polar Capital | 2.54 mm | $98.88 bn |
Capital International Investors | 2.48 mm | $96.53 bn |
BLK BlackRock | 2.10 mm | $81.72 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | Sherry Aulin | Common Shares | Sell | Dispose S | No | No | 41.19 | 11,510 | 474.10 k | 0 |
18 Dec 24 | Sherry Aulin | Common Shares | Payment of exercise | Dispose F | No | No | 41.28 | 4,490 | 185.35 k | 11,510 |
18 Dec 24 | Sherry Aulin | Common Shares | Option exercise | Acquire M | No | No | 11.58 | 16,000 | 185.28 k | 16,000 |
18 Dec 24 | Sherry Aulin | Common Shares | Sell | Dispose S | No | No | 41.23 | 7,199 | 296.81 k | 0 |
18 Dec 24 | Sherry Aulin | Common Shares | Payment of exercise | Dispose F | No | No | 41.28 | 2,135 | 88.13 k | 7,199 |
18 Dec 24 | Sherry Aulin | Common Shares | Option exercise | Acquire M | No | No | 9.44 | 9,334 | 88.11 k | 9,334 |
18 Dec 24 | Sherry Aulin | Stock Option Common Shares | Option exercise | Dispose M | No | No | 11.58 | 16,000 | 185.28 k | 6,000 |
18 Dec 24 | Sherry Aulin | Stock Option Common Shares | Option exercise | Dispose M | No | No | 9.44 | 9,334 | 88.11 k | 0 |
22 Nov 24 | Patou Gary | Common Shares | Sell | Dispose S | No | No | 41.05 | 2,040 | 83.74 k | 23,573 |
22 Nov 24 | Patou Gary | Common Shares | Payment of exercise | Dispose F | No | No | 39.8 | 1,046 | 41.63 k | 25,613 |